Welcome to LookChem.com Sign In|Join Free

CAS

  • or

103946-54-9

Post Buying Request

103946-54-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

103946-54-9 Usage

Uses

4''-Methyl-2,2''-bipyridine-4-carboxylic acid

Check Digit Verification of cas no

The CAS Registry Mumber 103946-54-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,3,9,4 and 6 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 103946-54:
(8*1)+(7*0)+(6*3)+(5*9)+(4*4)+(3*6)+(2*5)+(1*4)=119
119 % 10 = 9
So 103946-54-9 is a valid CAS Registry Number.

103946-54-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-(4-methylpyridin-2-yl)pyridine-4-carboxylic acid

1.2 Other means of identification

Product number -
Other names 4-4-carboxyl-4'-methyl-2,2'-bipyridine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:103946-54-9 SDS

103946-54-9Synthetic route

4,4'-dimethyl-2,2'-bipyridines
1134-35-6

4,4'-dimethyl-2,2'-bipyridines

4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

Conditions
ConditionsYield
With selenium(IV) oxide; sulfuric acid98%
Stage #1: 4,4'-dimethyl-2,2'-bipyridines With selenium(IV) oxide In 1,4-dioxane for 30h; Reflux;
Stage #2: With silver nitrate; sodium hydroxide In ethanol; water for 24h;
77%
Stage #1: 4,4'-dimethyl-2,2'-bipyridines With selenium(IV) oxide In 1,4-dioxane for 16h; Oxidation; Heating;
Stage #2: With silver(l) oxide Oxidation;
72%
4'-methyl-2,2'-bipyridine-4-carboxylaldehyde
104704-09-8

4'-methyl-2,2'-bipyridine-4-carboxylaldehyde

4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

Conditions
ConditionsYield
With silver nitrate; sodium hydroxide In ethanol for 24h; Darkness;82%
With silver nitrate; sodium hydroxide In ethanol; water at 20℃;80%
Stage #1: 4'-methyl-2,2'-bipyridine-4-carboxylaldehyde With silver nitrate In ethanol for 0.333333h;
Stage #2: With sodium hydroxide In ethanol at 25℃; for 15h; Darkness;
80%
4,4'-dimethyl-2,2'-bipyridines
1134-35-6

4,4'-dimethyl-2,2'-bipyridines

A

2,2'-Bipyridine-4,4'-dicarboxylic acid
6813-38-3

2,2'-Bipyridine-4,4'-dicarboxylic acid

B

4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

Conditions
ConditionsYield
With potassium permanganate; sulfuric acid for 12h; Heating;A 45%
B 4%
With manganese(II) sulfate; potassium permanganate In pyridine; water for 120h; Ambient temperature;A n/a
B 7%
With sodium hydroxide; selenium(IV) oxide; silver nitrate 1.) 1,4-dioxane, reflux, 24 h, 2.) EtOH, water, 15 h; Yield given. Multistep reaction. Yields of byproduct given;
With chromium(VI) oxide; periodic acid In dichloromethane; acetonitrile at 20℃; for 16h; Overall yield = 0.099 g;A 35 %Spectr.
B 6 %Spectr.
4,4'-dimethyl-2,2'-bipyridines
1134-35-6

4,4'-dimethyl-2,2'-bipyridines

A

4'-methyl-2,2'-bipyridine-4-carboxylaldehyde
104704-09-8

4'-methyl-2,2'-bipyridine-4-carboxylaldehyde

B

4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

Conditions
ConditionsYield
With selenium(IV) oxide In 1,4-dioxane for 72h;A 29%
B n/a
picoline
108-89-4

picoline

4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: manganese(IV) oxide; palladium on activated charcoal / neat (no solvent) / 168 h / 140 °C
2.1: selenium(IV) oxide / 1,4-dioxane / 24 h / Reflux
2.2: 20 °C
View Scheme
4,4'-dimethyl-2,2'-bipyridines
1134-35-6

4,4'-dimethyl-2,2'-bipyridines

4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

Conditions
ConditionsYield
With selenium(IV) oxide; sulfuric acid98%
Stage #1: 4,4'-dimethyl-2,2'-bipyridines With selenium(IV) oxide In 1,4-dioxane for 30h; Reflux;
Stage #2: With silver nitrate; sodium hydroxide In ethanol; water for 24h;
77%
Stage #1: 4,4'-dimethyl-2,2'-bipyridines With selenium(IV) oxide In 1,4-dioxane for 16h; Oxidation; Heating;
Stage #2: With silver(l) oxide Oxidation;
72%
4'-methyl-2,2'-bipyridine-4-carboxylaldehyde
104704-09-8

4'-methyl-2,2'-bipyridine-4-carboxylaldehyde

4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

Conditions
ConditionsYield
With silver nitrate; sodium hydroxide In ethanol for 24h; Darkness;82%
With silver nitrate; sodium hydroxide In ethanol; water at 20℃;80%
Stage #1: 4'-methyl-2,2'-bipyridine-4-carboxylaldehyde With silver nitrate In ethanol for 0.333333h;
Stage #2: With sodium hydroxide In ethanol at 25℃; for 15h; Darkness;
80%
4,4'-dimethyl-2,2'-bipyridines
1134-35-6

4,4'-dimethyl-2,2'-bipyridines

A

2,2'-Bipyridine-4,4'-dicarboxylic acid
6813-38-3

2,2'-Bipyridine-4,4'-dicarboxylic acid

B

4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

Conditions
ConditionsYield
With potassium permanganate; sulfuric acid for 12h; Heating;A 45%
B 4%
With manganese(II) sulfate; potassium permanganate In pyridine; water for 120h; Ambient temperature;A n/a
B 7%
With sodium hydroxide; selenium(IV) oxide; silver nitrate 1.) 1,4-dioxane, reflux, 24 h, 2.) EtOH, water, 15 h; Yield given. Multistep reaction. Yields of byproduct given;
With chromium(VI) oxide; periodic acid In dichloromethane; acetonitrile at 20℃; for 16h; Overall yield = 0.099 g;A 35 %Spectr.
B 6 %Spectr.
4,4'-dimethyl-2,2'-bipyridines
1134-35-6

4,4'-dimethyl-2,2'-bipyridines

A

4'-methyl-2,2'-bipyridine-4-carboxylaldehyde
104704-09-8

4'-methyl-2,2'-bipyridine-4-carboxylaldehyde

B

4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

Conditions
ConditionsYield
With selenium(IV) oxide In 1,4-dioxane for 72h;A 29%
B n/a
picoline
108-89-4

picoline

4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1.1: manganese(IV) oxide; palladium on activated charcoal / neat (no solvent) / 168 h / 140 °C
2.1: selenium(IV) oxide / 1,4-dioxane / 24 h / Reflux
2.2: 20 °C
View Scheme
4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

N,N`-dimethylethylenediamine
110-70-3

N,N`-dimethylethylenediamine

4'-methyl-[2,2']bipyridinyl-4-carboxylic acid methyl-(2-methylamino-ethyl)-amide
524957-05-9

4'-methyl-[2,2']bipyridinyl-4-carboxylic acid methyl-(2-methylamino-ethyl)-amide

Conditions
ConditionsYield
Stage #1: 4'-methyl-2,2'-bipyridine-4-carboxylic acid With 1,1'-carbonyldiimidazole In tetrahydrofuran at 60℃;
Stage #2: N,N`-dimethylethylenediamine In tetrahydrofuran at 20℃;
100%
meso-tetrakis-[4-(aminoethoxy-ethoxyethyl-aminocarbonyl) phenyl] porphyrin

meso-tetrakis-[4-(aminoethoxy-ethoxyethyl-aminocarbonyl) phenyl] porphyrin

4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

C120H118N20O16

C120H118N20O16

Conditions
ConditionsYield
Stage #1: 4'-methyl-2,2'-bipyridine-4-carboxylic acid With benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; for 0.5h;
Stage #2: meso-tetrakis-[4-(aminoethoxy-ethoxyethyl-aminocarbonyl) phenyl] porphyrin With dmap In N,N-dimethyl-formamide for 24h; Darkness;
96%
N-(2,3-dibenzyloxybenzoyl)-diaminobutane hydrochloride

N-(2,3-dibenzyloxybenzoyl)-diaminobutane hydrochloride

4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

1-N-[(4'-methyl-2,2'-bipyridyl)-4-carboxy]-4-N'-(2,3-dibenzyloxybenzoyl)-1,4-diaminobutane

1-N-[(4'-methyl-2,2'-bipyridyl)-4-carboxy]-4-N'-(2,3-dibenzyloxybenzoyl)-1,4-diaminobutane

Conditions
ConditionsYield
With fluorophosphate; O-(1H-benzotriazol-1-yl)-N,N,N',N'-tetramethyluronium hexafluorophosphate; N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃;95%
4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

aniline
62-53-3

aniline

4-methyl-N-phenyl-(2,2'-bipyridine)-4-carboxamide
1447716-06-4

4-methyl-N-phenyl-(2,2'-bipyridine)-4-carboxamide

Conditions
ConditionsYield
Stage #1: 4'-methyl-2,2'-bipyridine-4-carboxylic acid With thionyl chloride for 2h; Reflux;
Stage #2: aniline With triethylamine In tetrahydrofuran at 60℃;
95%
Ru(4,7-diphenyl-1,10-phenanthroline)2Cl2*DMF*H2O

Ru(4,7-diphenyl-1,10-phenanthroline)2Cl2*DMF*H2O

4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

[Ru(4,7-diphenyl-1,10-phenanthroline)2(4-carboxy-4'-methyl-2,2'-bipyridine)][Cl]2*5H2O

[Ru(4,7-diphenyl-1,10-phenanthroline)2(4-carboxy-4'-methyl-2,2'-bipyridine)][Cl]2*5H2O

Conditions
ConditionsYield
With sodium acetate; hydrochloric acid In methanol; water soln. Ru complex, ligand, and NaOAc in aq. MeOH was heated to reflux for24 h; soln. was cooled to room temp., concd., adjusted to pH 1 by HCl, aq. NaCl was added, ppt. was filtered, dissolved in MeOH and evapd., residue was dissolved in CH2Cl2 and filtered, benzene was added, ppt. was filtered, washed, dried in vacuo; elem. anal.;92%
ammonium hexafluorophosphate

ammonium hexafluorophosphate

cis-dichloro(2,2′-bipyridine)ruthenium(II)chloride

cis-dichloro(2,2′-bipyridine)ruthenium(II)chloride

4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

bis(2,2'-bipyridine)(4'-methyl-[2,2'-bipyridine]-4-carboxylic acid)ruthenium(II) bis(hexafluorophosphate)

bis(2,2'-bipyridine)(4'-methyl-[2,2'-bipyridine]-4-carboxylic acid)ruthenium(II) bis(hexafluorophosphate)

Conditions
ConditionsYield
In ethanol soln. of Ru complex in EtOH stirred under N2 for 10 min; 0.5 equiv. of ligand added; refluxed for 5 h; cooled to 25°C; satd. aq. soln. of NH4PF6 added; filtered;91%
potassium hexafluorophosphate
17084-13-8

potassium hexafluorophosphate

[Ru(2,2'-bipyridine)(CO)Cl2]2
221362-55-6, 41060-99-5

[Ru(2,2'-bipyridine)(CO)Cl2]2

4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

cis-carbonylchloro-(2,2'-bipyridine)(4'-methyl-2,2'-bipyridine-4-carboxylic acid)ruthenium(II) hexafluorophosphate hydrate

cis-carbonylchloro-(2,2'-bipyridine)(4'-methyl-2,2'-bipyridine-4-carboxylic acid)ruthenium(II) hexafluorophosphate hydrate

Conditions
ConditionsYield
In 2-methoxy-ethanol; water bipyridine was added to soln. of Ru complex in methoxyethanol under N2; refluxed at 120°C for 2 h; evapd. (vac.); H2O was added; sonicated for 5 min; cooled to 4°C; filtered; mixed with aq. KPF6; filtered; washed (H2O, H2O/EtOH, 1/1); dried at 70°C in air; elem. anal.;91%
tetrakis(4-aminophenyl)porphyrin
22112-84-1

tetrakis(4-aminophenyl)porphyrin

4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

5,10,15,20-tetrakis[4-(4-methyl-2,2'-pibyridine-4'-carboxyamidyl)phenyl]porphyrin

5,10,15,20-tetrakis[4-(4-methyl-2,2'-pibyridine-4'-carboxyamidyl)phenyl]porphyrin

Conditions
ConditionsYield
Stage #1: 4'-methyl-2,2'-bipyridine-4-carboxylic acid With pyridine; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride for 0.166667h;
Stage #2: tetrakis(4-aminophenyl)porphyrin at 20℃; for 3h;
91%
bis[dichloro(pentamethylcyclopentadienyl)iridium(III)]
12354-84-6, 12354-85-7

bis[dichloro(pentamethylcyclopentadienyl)iridium(III)]

ammonium hexafluorophosphate

ammonium hexafluorophosphate

4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

[(1,2,3,4,5-pentamethylcyclopentadiene)Ir(4-methyl-4′-carboxy-2,2′-bipyridine)Cl]PF6

[(1,2,3,4,5-pentamethylcyclopentadiene)Ir(4-methyl-4′-carboxy-2,2′-bipyridine)Cl]PF6

Conditions
ConditionsYield
Stage #1: bis[dichloro(pentamethylcyclopentadienyl)iridium(III)]; 4'-methyl-2,2'-bipyridine-4-carboxylic acid In methanol for 18h;
Stage #2: ammonium hexafluorophosphate at 3.84℃; for 18h;
91%
ammonium hexafluorophosphate

ammonium hexafluorophosphate

Ru(II)(4,4'-diethylamide-2,2'-bipyridine)2Cl2*2H2O

Ru(II)(4,4'-diethylamide-2,2'-bipyridine)2Cl2*2H2O

4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

[Ru(II)(4,4'-diethylamide-2,2'-bipyridine)2(4-carboxylicacid-4'-methyl-2,2'-bipyridine)](PF6)2

[Ru(II)(4,4'-diethylamide-2,2'-bipyridine)2(4-carboxylicacid-4'-methyl-2,2'-bipyridine)](PF6)2

Conditions
ConditionsYield
With NaH2PO4; Na2HPO4 In ethanol; water Ru complex and ligand (molar ratio 1:1.2) refluxed in EtOH-H2O for 17 h; dissolved in MeCN; deionized water (NaH2PO4-Na2HPO4 buffer) added slowly; filtered; sepd. by cation-exchange chromy. (Sephadex, NaCl soln.); pptd. by adding excess of NH4PF6 in H2O; acidified with dilute HCl; cooled to 0°C for 2 h; filtered; rinsed with dilute aq. NH4PF6 (acidic) and Et2O; elem. anal.;90%
C36H45N7O10S*ClH

C36H45N7O10S*ClH

4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

C48H53N9O11S

C48H53N9O11S

Conditions
ConditionsYield
Stage #1: 4'-methyl-2,2'-bipyridine-4-carboxylic acid With benzotriazol-1-ol; dicyclohexyl-carbodiimide In tetrahydrofuran; N,N-dimethyl-formamide for 0.5h; Cooling with ice;
Stage #2: C36H45N7O10S*ClH In tetrahydrofuran; N,N-dimethyl-formamide at 20℃; for 14h; pH=8 - 9;
89%
ammonium hexafluorophosphate

ammonium hexafluorophosphate

[iridium(III)(μ-chloro)(2-phenylpyridine)2]2

[iridium(III)(μ-chloro)(2-phenylpyridine)2]2

4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

iridium(III) [bis(C,N-2-phenylpyridine)-N,N-4-methyl-4'-carboxy-2,2'-bipyridine] hexafluorophosphate

iridium(III) [bis(C,N-2-phenylpyridine)-N,N-4-methyl-4'-carboxy-2,2'-bipyridine] hexafluorophosphate

Conditions
ConditionsYield
In methanol; dichloromethane suspn. of Ir complex in MeOH added to suspn. of ligand in CH2Cl2; heatedto reflux with stirring for 2 h; cooled to room temp.; satd. soln. of N H4PF6 in MeOH added; stirred for 30 min; vol. reduced under vac.; filtered; ppt. washed with ether; extd. into CH2Cl2; solvent removed under reduced pressure; elem. anal.;88%
ammonium hexafluorophosphate

ammonium hexafluorophosphate

Λ-bis(2,2'-bypyridine)bis(pyridine)ruthenium(II) O,O'-dibenzoyltartrate

Λ-bis(2,2'-bypyridine)bis(pyridine)ruthenium(II) O,O'-dibenzoyltartrate

4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

Λ-bis(2,2'-bipyridine)(4-methyl-2,2'-bipyridine-4-carboxylic acid)ruthenium(II) (PF6)2

Λ-bis(2,2'-bipyridine)(4-methyl-2,2'-bipyridine-4-carboxylic acid)ruthenium(II) (PF6)2

Conditions
ConditionsYield
With NaOAc; H2SO4 In water; ethylene glycol Ru complex, ligand, NaOAc, H2O and ethylene glycol heated at 120°C overnight, concd., H2SO4 added (to pH=1), H2O added, filtered, pptd. with aq. NH4PF6; filtered, washed with water, dried in vac.;85%
With sodium acetate; ethylene glycol; H2SO4 In water Ru-contg. compd. (0.419 mmol), a ligand (1 mmol), NaCH3CO2 (2.7 mmol), H2O, and ethylene glycol were heated at 120°C for 1 night; pH = 1 (H2SO4); H2O was added; the mixt. was filtered; addn. of satd. aq. soln.of NH4PF6; the complex was filtered, washed with H2O and dried under vac.;85%
ammonium hexafluorophosphate

ammonium hexafluorophosphate

Δ-bis(2,2'-bypyridine)bis(pyridine)ruthenium(II) O,O'-dibenzoyltartrate

Δ-bis(2,2'-bypyridine)bis(pyridine)ruthenium(II) O,O'-dibenzoyltartrate

4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

Δ-bis(2,2'-bipyridine)(4-methyl-2,2'-bipyridine-4-carboxylic acid)ruthenium(II) (PF6)2

Δ-bis(2,2'-bipyridine)(4-methyl-2,2'-bipyridine-4-carboxylic acid)ruthenium(II) (PF6)2

Conditions
ConditionsYield
With NaOAc; H2SO4 In water; ethylene glycol Ru complex, ligand, NaOAc, H2O and ethylene glycol heated at 120°C overnight, concd., H2SO4 added (to pH=1), H2O added, filtered, pptd. with aq. NH4PF6; filtered, washed with water, dried in vac.;85%
With sodium acetate; ethylene glycol; H2SO4 In water Ru-contg. compd. (0.419 mmol), a ligand (1 mmol), NaCH3CO2 (2.7 mmol), H2O, and ethylene glycol were heated at 120°C for 1 night; pH = 1 (H2SO4); H2O was added; the mixt. was filtered; addn. of satd. aq. soln.of NH4PF6; the complex was filtered, washed with H2O and dried under vac.;85%
ammonium hexafluorophosphate

ammonium hexafluorophosphate

chloridobis(2-phenyl-pyridine)rhodium(III) dimer
33915-80-9

chloridobis(2-phenyl-pyridine)rhodium(III) dimer

water
7732-18-5

water

4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

rhodium(III) [bis(C,N-2-phenylpyridine)-N,N-4-methyl-4'-carboxy-2,2'-bipyridine] hexafluorophosphate dihydrate

rhodium(III) [bis(C,N-2-phenylpyridine)-N,N-4-methyl-4'-carboxy-2,2'-bipyridine] hexafluorophosphate dihydrate

Conditions
ConditionsYield
In methanol; dichloromethane soln. of Rh complex in CH2Cl2 added to suspn. of ligand in MeOH; heated to reflux with stirring for 3 h; cooled to room temp.; satd. soln. of NH4PF6 in MeOH added; stirred for 30 min; vol. reduced under vac.; filtered; ppt. washed with ether; extd. into acetone; solvent removed under reduced pressure; extd. into CH2Cl2; filtered; elem. anal.;85%
C51H50N9O3(3+)*3I(1-)*3C2HF3O2

C51H50N9O3(3+)*3I(1-)*3C2HF3O2

4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

C63H58N11O4(3+)*3I(1-)*3C2HF3O2

C63H58N11O4(3+)*3I(1-)*3C2HF3O2

Conditions
ConditionsYield
Stage #1: 4'-methyl-2,2'-bipyridine-4-carboxylic acid With 4-methyl-morpholine; 2-chloro-4,6-dimethoxy-1 ,3,5-triazine In N,N-dimethyl-formamide at 0℃; for 4h;
Stage #2: C51H50N9O3(3+)*3I(1-)*3C2HF3O2 In N,N-dimethyl-formamide at 20℃; for 24h; Darkness;
85%
cis-dichlorobis(2,2′-bipyridine)ruthenium(II)
345911-20-8, 19542-80-4, 158060-65-2, 34795-02-3, 15746-57-3

cis-dichlorobis(2,2′-bipyridine)ruthenium(II)

ammonium hexafluorophosphate

ammonium hexafluorophosphate

4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

bis(2,2'-bipyridine)(4'-methyl-[2,2'-bipyridine]-4-carboxylic acid)ruthenium(II) bis(hexafluorophosphate)

bis(2,2'-bipyridine)(4'-methyl-[2,2'-bipyridine]-4-carboxylic acid)ruthenium(II) bis(hexafluorophosphate)

Conditions
ConditionsYield
Stage #1: cis-dichlorobis(2,2′-bipyridine)ruthenium(II); 4'-methyl-2,2'-bipyridine-4-carboxylic acid In ethanol; water for 5h; Reflux; Darkness; Inert atmosphere;
Stage #2: ammonium hexafluorophosphate In water
85%
Stage #1: cis-dichlorobis(2,2′-bipyridine)ruthenium(II); 4'-methyl-2,2'-bipyridine-4-carboxylic acid In methanol; water for 2h; Reflux; Inert atmosphere;
Stage #2: ammonium hexafluorophosphate In water
74%
Stage #1: cis-dichlorobis(2,2′-bipyridine)ruthenium(II) In methanol Inert atmosphere; Schlenk technique; Reflux;
Stage #2: 4'-methyl-2,2'-bipyridine-4-carboxylic acid Inert atmosphere; Schlenk technique; Reflux;
Stage #3: ammonium hexafluorophosphate Inert atmosphere; Schlenk technique;
cis-dichlorobis(2,2′-bipyridine)ruthenium(II)
345911-20-8, 19542-80-4, 158060-65-2, 34795-02-3, 15746-57-3

cis-dichlorobis(2,2′-bipyridine)ruthenium(II)

4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

(4′-methyl-2,2′-bipyridyl-4-carboxylic acid)bis(2,2′-bipyridine)-ruthenium chloride

(4′-methyl-2,2′-bipyridyl-4-carboxylic acid)bis(2,2′-bipyridine)-ruthenium chloride

Conditions
ConditionsYield
Stage #1: cis-dichlorobis(2,2′-bipyridine)ruthenium(II); 4'-methyl-2,2'-bipyridine-4-carboxylic acid With n-butylamine hydrochloride In ethanol for 5h; Reflux; Inert atmosphere; Darkness;
Stage #2: In acetone; acetonitrile
85%
4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

N,2-[(1,1-dimethylethoxy)carbonyl]-L-lysine methyl ester hydrochloride
99532-86-2

N,2-[(1,1-dimethylethoxy)carbonyl]-L-lysine methyl ester hydrochloride

(S)-2-tert-Butoxycarbonylamino-6-[(4'-methyl-[2,2']bipyridinyl-4-carbonyl)-amino]-hexanoic acid methyl ester

(S)-2-tert-Butoxycarbonylamino-6-[(4'-methyl-[2,2']bipyridinyl-4-carbonyl)-amino]-hexanoic acid methyl ester

Conditions
ConditionsYield
With 4-methyl-morpholine; dmap; (benzotriazo-1-yloxy)tris(dimethylamino)phosphonium hexafluorophosphate; 1-hydroxybenzotriazol-hydrate In N,N-dimethyl-formamide for 24h; Ambient temperature;84%
tert-butyl N-(6-aminohexyl)carbamate
51857-17-1

tert-butyl N-(6-aminohexyl)carbamate

4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

tert-butyl (6-(4’-methyl-[2,2’-bipyridine]-4-carboxamido)hexyl)carbamate
1186077-56-4

tert-butyl (6-(4’-methyl-[2,2’-bipyridine]-4-carboxamido)hexyl)carbamate

Conditions
ConditionsYield
Stage #1: 4'-methyl-2,2'-bipyridine-4-carboxylic acid With 1,1'-carbonyldiimidazole In N,N-dimethyl-formamide at 60℃; for 0.5h; Inert atmosphere;
Stage #2: tert-butyl N-(6-aminohexyl)carbamate In N,N-dimethyl-formamide at 60℃; for 16h; Inert atmosphere;
83%
With dmap; benzotriazol-1-ol; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; triethylamine In dichloromethane Inert atmosphere;51.43%
ammonium hexafluorophosphate

ammonium hexafluorophosphate

[(4,7-diphenyl-1,10-phenanthroline)2RuCl2]
106548-41-8, 889112-21-4

[(4,7-diphenyl-1,10-phenanthroline)2RuCl2]

4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

(4'-methyl-2,2'-bipyridinyl-4-carboxylic acid)bis(4,7-diphenyl-1,10-phenanthroline)ruthenium(II) hexafluorophosphate

(4'-methyl-2,2'-bipyridinyl-4-carboxylic acid)bis(4,7-diphenyl-1,10-phenanthroline)ruthenium(II) hexafluorophosphate

Conditions
ConditionsYield
Stage #1: [(4,7-diphenyl-1,10-phenanthroline)2RuCl2]; 4'-methyl-2,2'-bipyridine-4-carboxylic acid In ethanol; water Inert atmosphere; Reflux;
Stage #2: ammonium hexafluorophosphate In water
83%
hexafluorophosphoric acid

hexafluorophosphoric acid

Λ-bis(2,2'-bypyridine)bis(pyridine)ruthenium(II) O,O'-dibenzoyltartrate

Λ-bis(2,2'-bypyridine)bis(pyridine)ruthenium(II) O,O'-dibenzoyltartrate

4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

Λ-bis(2,2'-bipyridine)(4-methyl-2,2'-bipyridine-4-carboxylic acid)ruthenium(II) (PF6)2

Λ-bis(2,2'-bipyridine)(4-methyl-2,2'-bipyridine-4-carboxylic acid)ruthenium(II) (PF6)2

Conditions
ConditionsYield
In ethanol; water suspn. of Ru complex and ligand in 70% aq. EtOH heated under reflux overnight, cooled to room temp., concd. (vac.), stored overnight, filtered, solid washed with H2O, combined filtrates acidified to pH 1 by dropwise addn. of 60% aq. HPF6 with stirring; ppt. filtered off, washed with H2O and diethyl ether, dried at 110°C overnight; elem. anal.;82%
hexafluorophosphoric acid

hexafluorophosphoric acid

Δ-bis(2,2'-bypyridine)bis(pyridine)ruthenium(II) O,O'-dibenzoyltartrate

Δ-bis(2,2'-bypyridine)bis(pyridine)ruthenium(II) O,O'-dibenzoyltartrate

4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

Δ-bis(2,2'-bipyridine)(4-methyl-2,2'-bipyridine-4-carboxylic acid)ruthenium(II) (PF6)2

Δ-bis(2,2'-bipyridine)(4-methyl-2,2'-bipyridine-4-carboxylic acid)ruthenium(II) (PF6)2

Conditions
ConditionsYield
In ethanol; water suspn. of Ru complex and ligand in 70% aq. EtOH heated under reflux overnight, cooled to room temp., concd. (vac.), stored overnight, filtered, solid washed with H2O, combined filtrates acidified to pH 1 by dropwise addn. of 60% aq. HPF6 with stirring; ppt. filtered off, washed with H2O and diethyl ether, dried at 110°C overnight; elem. anal.;82%
4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

5-(p-aminophenyl)-10,15,20-triphenylporphine
67605-64-5

5-(p-aminophenyl)-10,15,20-triphenylporphine

5-[4-(4-methyl-2,2'-pibyridine-4'-carboxyamidyl)phenyl]-10,15,20-triphenylporphyrin

5-[4-(4-methyl-2,2'-pibyridine-4'-carboxyamidyl)phenyl]-10,15,20-triphenylporphyrin

Conditions
ConditionsYield
Stage #1: 4'-methyl-2,2'-bipyridine-4-carboxylic acid With pyridine; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride for 0.166667h;
Stage #2: 5-(p-aminophenyl)-10,15,20-triphenylporphine at 20℃; for 1h;
82%
N-(4-(3'-aminophenyl)thiazol-2-yl)acetamide
134812-30-9

N-(4-(3'-aminophenyl)thiazol-2-yl)acetamide

4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

C23H19N5O2S

C23H19N5O2S

Conditions
ConditionsYield
With dmap; 1-hydroxy-7-aza-benzotriazole; 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride In N,N-dimethyl-formamide at 20℃; for 6h;82%
4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

N4,N4'-Dimethyl-N4-(4'-methyl-[2,2']bipyridinyl-4-ylmethyl)-biphenyl-4,4'-diamine
191601-42-0

N4,N4'-Dimethyl-N4-(4'-methyl-[2,2']bipyridinyl-4-ylmethyl)-biphenyl-4,4'-diamine

4'-Methyl-[2,2']bipyridinyl-4-carboxylic acid methyl-{4'-[methyl-(4'-methyl-[2,2']bipyridinyl-4-ylmethyl)-amino]-biphenyl-4-yl}-amide

4'-Methyl-[2,2']bipyridinyl-4-carboxylic acid methyl-{4'-[methyl-(4'-methyl-[2,2']bipyridinyl-4-ylmethyl)-amino]-biphenyl-4-yl}-amide

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine; bromo-tris(1-pyrrolidinyl)phosphonium hexafluorophosphate In dichloromethane Ambient temperature;80%
hexafluorophosphoric acid

hexafluorophosphoric acid

cis-dichloridobis(1,10-phenanthroline)ruthenium(II)

cis-dichloridobis(1,10-phenanthroline)ruthenium(II)

4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

[Ru(phen)2(4'-methyl-1,10-phenanthroline-4-carboxylic acid)(PF6)2]

[Ru(phen)2(4'-methyl-1,10-phenanthroline-4-carboxylic acid)(PF6)2]

Conditions
ConditionsYield
Stage #1: cis-dichloridobis(1,10-phenanthroline)ruthenium(II); 4'-methyl-2,2'-bipyridine-4-carboxylic acid In ethanol for 12h; Reflux;
Stage #2: hexafluorophosphoric acid With ammonium hexafluorophosphate pH=1;
80%
methanol
67-56-1

methanol

4'-methyl-2,2'-bipyridine-4-carboxylic acid
103946-54-9

4'-methyl-2,2'-bipyridine-4-carboxylic acid

methyl 4'-methyl-2,2'-bipyridine-4-carboxylate
142593-05-3

methyl 4'-methyl-2,2'-bipyridine-4-carboxylate

Conditions
ConditionsYield
With sulfuric acid at 0℃; Inert atmosphere; Reflux;79%

103946-54-9Relevant articles and documents

DNA interaction and photonicking properties of DNA-targeted acridine (2,2′-bipyridine)platinum(II) complexes

Gude, Lourdes,Fernandez, Maria-Jose,Grant, Kathryn B,Lorente, Antonio

, p. 3135 - 3139 (2002)

Synthesis of two (2,2′-bipyridine)platinum(II) complexes tethered to one or two acridine chromophores is reported. These acridine complexes efficiently unwind and photocleave supercoiled plasmid DNA under physiological conditions of temperature and pH.

Synthesis and Biological Evaluation of Ru(II) and Pt(II) Complexes Bearing Carboxyl Groups as Potential Anticancer Targeted Drugs

Martínez, Mángeles,Carranza, M. Pilar,Massaguer, Anna,Santos, Lucia,Organero, Juan A.,Aliende, Cristina,De Llorens, Rafael,Ng-Choi, Iteng,Feliu, Lidia,Planas, Marta,Rodríguez, Ana M.,Manzano, Blanca R.,Espino, Gustavo,Jalón, Félix A.

, p. 13679 - 13696 (2017)

The synthesis and characterization of Pt(II) (1 and 2) and Ru(II) arene (3 and 4) or polypyridine (5 and 6) complexes is described. With the aim of having a functional group to form bioconjugates, one uncoordinated carboxyl group has been introduced in all complexes. Some of the complexes were selected for their potential in photodynamic therapy (PDT). The molecular structures of complexes 2 and 5, as well as that of the sodium salt of the 4′-(4-carboxyphenyl)-2,2′:6′,2″-terpyridine ligand (cptpy), were determined by X-ray diffraction. Different techniques were used to evaluate the binding capacity to model DNA molecules, and MTT cytotoxicity assays were performed against four cell lines. Compounds 3, 4, and 5 showed little tendency to bind to DNA and exhibited poor biological activity. Compound 2 behaves as bonded to DNA probably through a covalent interaction, although its cytotoxicity was very low. Compound 1 and possibly 6, both of which contain a cptpy ligand, were able to intercalate with DNA, but toxicity was not observed for 6. However, compound 1 was active in all cell lines tested. Clonogenic assays and apoptosis induction studies were also performed on the PC-3 line for 1. The photodynamic behavior for complexes 1, 5, and 6 indicated that their nuclease activity was enhanced after irradiation at = 447 nm. The cell viability was significantly reduced only in the case of 5. The different behavior in the absence or presence of light makes complex 5 a potential prodrug of interest in PDT. Molecular docking studies followed by molecular dynamics simulations for 1 and the counterpart without the carboxyl group confirmed the experimental data that pointed to an intercalation mechanism. The cytotoxicity of 1 and the potential of 5 in PDT make them good candidates for subsequent conjugation, through the carboxyl group, to "selected peptides" which could facilitate the selective vectorization of the complex toward receptors that are overexpressed in neoplastic cell lines.

A Multi-action and Multi-target RuII–PtIV Conjugate Combining Cancer-Activated Chemotherapy and Photodynamic Therapy to Overcome Drug Resistant Cancers

Gasser, Gilles,Gibson, Dan,Karges, Johannes,Tharaud, Micka?l,Yempala, Thirumal

, p. 7069 - 7075 (2020)

PtII complexes are commonly used to treat cancer. To reduce their side effects and improve their pharmacological properties, PtIV complexes are being developed as prodrug candidates that are activated by reduction in cancer cells. Concomitantly, RuII polypyridine complexes have gained much attention as photosensitizers for use in photodynamic therapy due to their attractive characteristics. In this article, a novel PtIV–RuII conjugate, which combines cancer activated chemotherapy with PDT, is presented. Upon entering the cancer cell, the PtIV centre is reduced to PtII and the axial ligands including the RuII complex and phenylbutyrate are released. As each component has its individual targets, the conjugate exerts a multi-target and multi-action effect with (photo-)cytotoxicity values upon irradiation up to 595 nm in the low nanomolar range in various (drug resistant) 2D monolayer cancer cells and 3D multicellular tumour spheroids.

Detection of NaCN in aqueous media using a calixarene-based fluoroionophore containing ruthenium(ii)-bipyridine as the fluorogenic unit

Maity, Debdeep,Vyas, Gaurav,Bhatt, Madhuri,Paul, Parimal

, p. 6151 - 6159 (2015)

A new molecular sensor containing calixarene and ruthenium(ii)-bipyridine as the fluorophore bridged by an amide moiety has been synthesised and characterized, and its anion binding properties have been investigated. It selectively detected cyanide in 95:5 water:acetonitrile when sodium salts of various anions such as F-, Cl-, Br-, I-, PO42-, IO4-, BO3-, CH3COO-, CN- and SO42- were investigated. The recognition event was monitored by fluorescence spectroscopy and the lower detection limit found was 70 ppb. However, when tetrabutylammonium salts of the same anions were used then, in addition to CN-, CH3COO- was also detected under similar experimental conditions. Interestingly, CN- exhibited substantial quenching, whereas CH3COO- showed an enhancement in emission intensity. The interaction of anions with the fluoroionophore was also monitored by electrochemical technique and the result obtained is consistent to that found by fluorogenic method. Binding constants were determined from emission titration, composition of the anion-complexes formed were determined from mass and emission titration data, mechanistic aspects of the interaction have been discussed with the aid of NMR data and the role of cations in the contrast fluorescent off and on behaviour has also been discussed. This sensor has also been used to estimate cyanide in real samples and the result obtained is satisfactory. This journal is

Shallow Distance Dependence for Proton-Coupled Tyrosine Oxidation in Oligoproline Peptides

Koronkiewicz, Brian,Swierk, John,Regan, Kevin,Mayer, James M.

, p. 12106 - 12118 (2020)

We have explored the kinetic effect of increasing electron transfer (ET) distance in a biomimetic, proton-coupled electron-transfer (PCET) system. Biological ET often occurs simultaneously with proton transfer (PT) in order to avoid the high-energy, charged intermediates resulting from the stepwise transfer of protons and electrons. These concerted proton-electron-transfer (CPET) reactions are implicated in numerous biological ET pathways. In many cases, PT is coupled to long-range ET. While many studies have shown that the rate of ET is sensitive to the distance between the electron donor and acceptor, extensions to biological CPET reactions are sparse. The possibility of a unique ET distance dependence for CPET reactions deserves further exploration, as this could have implications for how we understand biological ET. We therefore explored the ET distance dependence for the CPET oxidation of tyrosine in a model system. We prepared a series of metallopeptides with a tyrosine separated from a Ru(bpy)32+ complex by an oligoproline bridge of increasing length. Rate constants for intramolecular tyrosine oxidation were measured using the flash-quench transient absorption technique in aqueous solutions. The rate constants for tyrosine oxidation decreased by 125-fold with three added proline residues between tyrosine and the oxidant. By comparison, related intramolecular ET rate constants in very similar constructs were reported to decrease by 4-5 orders of magnitude over the same number of prolines. The observed shallow distance dependence for tyrosine oxidation is proposed to originate in part from the requirement for stronger oxidants, leading to a smaller hole-transfer effective tunneling barrier height. The shallow distance dependence observed here and extensions to distance-dependent CPET reactions have potential implications for long-range charge transfers.

Photosensitization of novel ruthenium-functionalized photoconductive polymers: Effect of ruthenium complex as photosensitizer

Moon, Jong-Sik,Kim, Chuntae,Kim, Won-Geun,Kim, Inhong,Kyhm, Kwangseuk,Oh, Jin-Woo,Kim, Nakjoong

, p. 141 - 147 (2015)

Owing to their efficient photo-charge generation, ruthenium derivatives are emerging as an important class of photosensitizers. Despite their promising characteristics, several deficiencies, such as the relatively low quantum yield and short lifetime of t

Synthesis and characterization of oligoproline-based molecular assemblies for light harvesting

Aldridge III, W. Steven,Hornstein, Brooks J.,Serron, Scafford,Dattelbaum, Dana M.,Schoonover, Jon R.,Meyer, Thomas J.

, p. 5186 - 5190 (2006)

Helical oligoproline arrays provide a structurally well-defined environment for building photochemical energy conversion assemblies. The use of solid-phase peptide synthesis (SPPS) to prepare four such arrays, consisting of 16, 17, 18, and 19 amino acid residues, is described here. Each array contains the chromophore [Rub′2m](PF6)2 (b′ = 4,4′-diethylamidocarbonyl-2,2′-bipyridine; m = 4-methyl-2,2′- dipyridine-4′-carboxylic acid) and the electron transfer donor PTZ (phenothiazine). The arrays differ systematically in the distance between the redox-active metal complex and PTZ sites. They have been used in photophysical studies to provide insight into the distance dependence of electron transfer. (J. Am. Chem. Soc. 2004, 126, 14506-14514). This work describes the synthesis, purification, and characterization of the oligoproline arrays, including a general procedure for the synthesis of related arrays.

Persistent photoconductivity in chemically modified single-wall carbon nanotubes

Khairoutdinov, Rafail F.,Doubova, Larissa V.,Haddon, Robert C.,Saraf, Laxmikant

, p. 19976 - 19981 (2004)

Control of the conductivity of single wall carbon nanotubes (SWNTs) is crucial for the use of carbon nanotubes in molecular electronics. We report a new fundamental characteristic of semiconducting SWNTs: the persistent photoconductivity of chemically modified carbon nanotube films. Illumination of carboxylated semiconducting SWNTs with ultraviolet or visible light causes a persistent decrease in the conductivity of semiconducting films. The photoinduced conductivity persists in the dark with a characteristic half-life of 35 s to 1.2 ?? 103 s at room temperature and an activation energy of 0.35 eV. Infrared illumination restores the conductivity of SWNT films. Ultraviolet and visible light illumination partially refills empty valence band states of chemically modified SWNTs by electron injection from the dopant sites. Photoinduced injection of electrons is accompanied by a decrease of the conductivity of the p-doped SWNT film, because of neutralization of holes by injected electrons. Covalent attachment of ruthenium(II)-tris(2,2a?2- bipyridine) (Ru(bpy)32+) to SWNTs makes carbon nanotubes sensitive to light that has been absorbed by the ruthenium complex and makes the carbon nanotubes persistently photoconductive. The photoconductivity of Ru(bpy)32+-SWNT films is presumably due to the injection of holes from *Ru(bpy)32+ to SWNT with a quantum yield of 0.55. Persistently photoconductive SWNTs have potential uses as nanosized optical switches, photodetectors, electrooptical information storage devices, and chemical sensors.

Metal-triggered radial self-assembly of collagen peptide fibers

Przybyla, David E.,Chmielewski, Jean

, p. 12610 - 12611 (2008)

A metal-triggered self-assembling collagen peptide was designed and synthesized to generate fibers through a radial growth mechanism. The assembly of the fibers was made possible through the placement of a bipyridine ligands within the center of the triple helix and was triggered by the addition of Fe(II). Copyright

Covalent hybrids based on Re(i) tricarbonyl complexes and polypyridine-functionalized polyoxometalate: Synthesis, characterization and electronic properties

Auvray, Thomas,Santoni, Marie-Pierre,Hasenknopf, Bernold,Hanan, Garry S.

, p. 10029 - 10036 (2017)

A series of [Re(CO)3Br(N^N)] (N^N = substituted 2,2′-bipyridine ligand) complexes based on polypyridine-functionalized Dawson polyoxometalate (1-3) has been synthesized. The new hybrids (4-6) were characterized by various analytical techniques, including absorption, vibrational and luminescence spectroscopies as well as electrochemistry. Both units, the polyoxometalate and the transition metal complex, retain their intrinsic properties. Their combination in the newly prepared hybrids results in improved photosensitization in the high-energy visible region. However, a complete quenching of the emission for the [Re(CO)3Br(N^N)] complexes is observed due to formation of a charge separated state, Re(ii)-POM-, as shown by quenching experiments as well as theoretical modelling via DFT.

Double-phosphorescence emission probe and preparation method thereof

-

Paragraph 0036; 0040; 0044; 0045, (2020/06/16)

The invention discloses a double-phosphorescence emission probe and a preparation method thereof; the double-phosphorescence emission probe capable of detecting oxygen and metal ions is constructed byutilizing the response of a bis(2-pyridylmethyl)amine structure to metal ions and the response of a double-phosphorescence emission iridium complex to oxygen. Compared with a single-phosphorescence emission iridium complex probe disclosed in the prior art, the double-phosphorescence emission probe provides a new idea for simultaneous detection of multiple detection targets by a single probe; thepreparation process of the double-phosphorescence emission iridium complex is simple, reaction conditions are mild, and operability is high.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 103946-54-9